Clinical Outcomes and Prognosis of Patients With Interstitial Lung Disease Undergoing Lung Cancer Surgery: A Propensity Score Matching Study

被引:3
作者
Ki, Min Seo [1 ]
Kim, Song Yee [1 ]
Kim, Eun Young [1 ]
Jung, Ji Ye [1 ]
Kang, Young Ae [1 ]
Park, Moo Suk [1 ]
Kim, Young Sam [1 ]
Park, Seong Yong [2 ]
Lee, Sang Hoon [1 ,3 ]
机构
[1] Yonsei Univ, Severance Hosp, Dept Internal Med, Div Pulmonol,Coll Med, Seoul, South Korea
[2] Sungkyunkwan Univ, Samsung Med Ctr, Dept Thorac & Cardiovasc Surg, Sch Med, Seoul, South Korea
[3] Yonsei Univ, Severance Hosp, Dept Internal Med, Div Pulmonol,Coll Med, 50-1 Yonsei Ro, Seoul, South Korea
关键词
ILD-GAP index; IPF; Non-IPF; Pulmonary resection; Survival; IDIOPATHIC PULMONARY-FIBROSIS; ACUTE EXACERBATION; STAGING SYSTEM; SURVIVAL; RESECTION; IMPACT; PREDICTORS; ALVEOLITIS; INDEX;
D O I
10.1016/j.cllc.2022.10.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We compared the prognosis after lung cancer surgery in 104 patients with ILD and 104 patients without ILD matched by key variables. Patients with ILD had worse survival. Concomitant IPF or high physiological severity of ILD was associated with worse survival. Evaluation of underlying ILD before surgery is thought to be helpful in predicting the prognosis after lung cancer surgery.Background: Patients with interstitial lung disease (ILD) may have a poor prognosis after lung cancer surgery because of respiratory complications and increased recurrence rates due to limited resection. Few studies have investigated prognosis after surgery by matching clinical variables between patients with and without ILD. Patients and Methods: Medical records of patients who underwent lung cancer surgery between January 2010 and August 2020 at a referral hospital in South Korea were reviewed. Patients with ILD were identified based on preoperative computed tomography findings. Through propensity score matching, the clinical outcomes and prognoses of patients with (ILD group) and without ILD (control group) were compared. Results: Of 1629 patients, 113 (6.9%) patients with ILD were identified, of whom 104 patients were matched. Before matching, patients with ILD had higher mean age, proportion of men, and rates of sublobar resection and squamous cell carcinoma than those without ILD. After matching, there was no significant difference in postoperative mortality rates between the control and ILD groups. The 5-year survival rate was significantly lower in the ILD group (66%) than in the control group (78.8%; P = .007). The 5-year survival rate of the ILD-GAP (Gender, Age, Physiology) stage III group (12.6%) was significantly lower than that of the ILD-GAP stage I (73.5%) and II groups (72.6%; P < .0001). Multivariable Cox analysis demonstrated that idiopathic pulmonary fibrosis, higher clinical stage, and recurrence were independent prognostic factors for mortality. Conclusion: Concomitant ILD negatively affects long-term prognosis after lung cancer surgery, and ILD subtype and physiological severity assessment help predict prognosis after surgery.
引用
收藏
页码:e27 / e38
页数:12
相关论文
共 40 条
  • [1] [Anonymous], 2020, CA Cancer J Clin, V70, P313, DOI [10.3322/caac.21492, 10.3322/caac.21609]
  • [2] INTERSTITIAL LUNG DISEASE IN A LUNG CANCER SCREENING PROGRAM: PREVALENCE AND ASSOCIATION WITH CANCER.
    Campo Ezquibela, Aranzazu
    Merino Hernandez, Amaia
    Gonzalez Gutierrez, Jessica
    Marin Oto, Marta
    Alcaide Ocana, Ana Belen
    De Torres Tajes, Juan Pablo
    Zulueta Frances, Javier
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [3] Acute Exacerbation of Idiopathic Pulmonary Fibrosis An International Working Group Report
    Collard, Harold R.
    Ryerson, Christopher J.
    Corte, Tamera J.
    Jenkins, Gisli
    Kondoh, Yasuhiro
    Lederer, David J.
    Lee, Joyce S.
    Maher, Toby M.
    Wells, Athol U.
    Antoniou, Katerina M.
    Behr, Juergen
    Brown, Kevin K.
    Cottin, Vincent
    Flaherty, Kevin R.
    Fukuoka, Junya
    Hansell, David M.
    Johkoh, Takeshi
    Kaminski, Naftali
    Kim, Dong Soon
    Kolb, Martin
    Lynch, David A.
    Myers, Jeffrey L.
    Raghu, Ganesh
    Richeldi, Luca
    Taniguchi, Hiroyuki
    Martinez, Fernando J.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 194 (03) : 265 - 275
  • [4] Neglectable benefit of searching for incidental findings in the Dutch-Belgian lung cancer screening trial (NELSON) using low-dose multidetector CT
    de Wiel, J. C. M. van
    Wang, Y.
    Xu, D. M.
    van der Zaag-Loonen, H. J.
    van der Jagt, E. J.
    van Klaveren, R. J.
    Oudkerk, M.
    [J]. EUROPEAN RADIOLOGY, 2007, 17 (06) : 1474 - 1482
  • [5] The Eighth Edition Lung Cancer Stage Classification
    Detterbeck, Frank C.
    Boffa, Daniel J.
    Kim, Anthony W.
    Tanoue, Lynn T.
    [J]. CHEST, 2017, 151 (01) : 193 - 203
  • [6] Lung Cancer Screening Rates During the COVID-19 Pandemic
    Fedewa, Stacey A.
    Bandi, Priti
    Smith, Robert A.
    Silvestri, Gerard A.
    Jemal, Ahmedin
    [J]. CHEST, 2022, 161 (02) : 586 - 589
  • [7] Lung Cancer in Combined Pulmonary Fibrosis and Emphysema A Series of 47 Western Patients
    Girard, Nicolas
    Marchand-Adam, Sylvain
    Naccache, Jean-Marc
    Borie, Raphael
    Urban, Thierry
    Jouneau, Stephane
    Marchand, Eric
    Ravel, Anne-Claire
    Kiakouama, Lize
    Etienne-Mastroianni, BeneDicte
    Cadranel, Jacques
    Cottin, Vincent
    Cordier, Jean-Francois
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (08) : 1162 - 1170
  • [8] Progression in the Management of Non-Idiopathic Pulmonary Fibrosis Interstitial Lung Diseases, Where Are We Now and Where We Would Like to Be
    Goos, Tinne
    De Sadeleer, Laurens J.
    Yserbyt, Jonas
    Verleden, Geert M.
    Vermant, Marie
    Verleden, Stijn E.
    Wuyts, Wim A.
    [J]. JOURNAL OF CLINICAL MEDICINE, 2021, 10 (06)
  • [9] Hao X, 2022, INTERACTIVE CARDIOVA
  • [10] Cryptogenic fibrosing alveolitis and lung cancer: the BTS study
    Harris, J. M.
    Johnston, I. D. A.
    Rudd, R.
    Taylor, A. J. Newman
    Cullinan, P.
    [J]. THORAX, 2010, 65 (01) : 70 - 76